The goal of IMPROV is to identify molecular mechanisms that contribute to lung injury and
long-term breathing problems in preterm infants by investigating two interrelated biochemical
pathways: the urea cycle-nitric oxide pathway and the glutathione pathway. The investigators
hypothesize that prematurity-related limitations in the function of these important
biochemical pathways contribute to respiratory disease risk over the first year of life.